Immunotech Laboratories Company Insiders
| IMMB Stock | USD 0.0001 0.00 0.00% |
Immunotech Laboratories employs about 4 people. The company is managed by 5 executives with a total tenure of roughly 18 years, averaging almost 3.0 years of service per executive, having 0.8 employees per reported executive. Analysis of Immunotech Laboratories' management performance can provide insight into the company performance.
| Harry Zhabilov Chairman Vice Chairman of the Board, Chief Science Officer |
Immunotech | Build AI portfolio with Immunotech Stock |
Immunotech Laboratories Management Team Effectiveness
As of December 28, 2025, Return On Tangible Assets is expected to decline to -1.15. The current year's Return On Capital Employed is expected to grow to -0.08. As of December 28, 2025, Return On Tangible Assets is expected to decline to -1.15. In addition to that, Intangibles To Total Assets is expected to decline to 0.71Immunotech Laboratories' management efficiency ratios could be used to measure how well Immunotech Laboratories manages its routine affairs as well as how well it operates its assets and liabilities.Immunotech Laboratories Workforce Comparison
Immunotech Laboratories is currently regarded as number one stock in number of employees category among its peers. The total workforce of Biotechnology industry is currently estimated at about 756. Immunotech Laboratories maintains roughly 4.0 in number of employees contributing less than 1% to stocks in Biotechnology industry.
Immunotech Laboratories Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Immunotech Laboratories Price Series Summation is a cross summation of Immunotech Laboratories price series and its benchmark/peer.
Immunotech Laboratories Notable Stakeholders
An Immunotech Laboratories stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Immunotech Laboratories often face trade-offs trying to please all of them. Immunotech Laboratories' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Immunotech Laboratories' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Zhabilov BSc | Vice Founder | Profile | |
| Harry Zhabilov | Vice Chairman of the Board, Chief Science Officer | Profile | |
| Billy Ray | Executive CFO | Profile | |
| Esq JD | Legal Counsel | Profile | |
| Edward Azizian | VP Research | Profile |
About Immunotech Laboratories Management Performance
The success or failure of an entity such as Immunotech Laboratories often depends on how effective the management is. Immunotech Laboratories management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Immunotech management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Immunotech management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (1.09) | (1.15) | |
| Return On Capital Employed | (0.08) | (0.08) | |
| Return On Assets | (0.05) | (0.06) | |
| Return On Equity | (0.09) | (0.09) |
Please note, the presentation of Immunotech Laboratories' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Immunotech Laboratories' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Immunotech Laboratories' management manipulating its earnings.
Immunotech Laboratories Workforce Analysis
Traditionally, organizations such as Immunotech Laboratories use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Immunotech Laboratories within its industry.Immunotech Laboratories Manpower Efficiency
Return on Immunotech Laboratories Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 244.4K | |
| Net Loss Per Executive | 195.5K |
Complementary Tools for Immunotech Stock analysis
When running Immunotech Laboratories' price analysis, check to measure Immunotech Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunotech Laboratories is operating at the current time. Most of Immunotech Laboratories' value examination focuses on studying past and present price action to predict the probability of Immunotech Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunotech Laboratories' price. Additionally, you may evaluate how the addition of Immunotech Laboratories to your portfolios can decrease your overall portfolio volatility.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |